Noble Genetics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Satisfied Charges ₹ 7.00 M
- Revenue Growth -17.69%
- Profit Growth 8.83%
- Ebitda -1.59%
- Net Worth 13.30%
- Total Assets 16.20%
About Noble Genetics
Noble Genetics Private Limited (NGPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 August 2008 and has a history of 16 years and five months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Manvar, Prasantkumar Manvar, Umeshkumar Panchani, and Two other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2008PTC054746
-
Company No.
054746
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Noble Genetics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Manvar
|
Director | 02-Oct-2020 | Current |
|
Prasantkumar Manvar
|
Director | 11-Aug-2008 | Current |
|
Umeshkumar Panchani
|
Director | 11-Aug-2008 | Current |
|
Ketankumar Bhalodia
|
Director | 02-Oct-2020 | Current |
|
Bipinkumar Vasoya
|
Director | 13-Dec-2022 | Current |
Financial Performance of Noble Genetics.
Noble Genetics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.69% decrease. The company also saw a slight improvement in profitability, with a 8.83% increase in profit. The company's net worth Soared by an impressive increase of 13.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Genetics?
Unlock access to Noble Genetics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Oasis LimitedAnkur Manvar, Prasantkumar Manvar and 2 more are mutual person
-
Jk Crop Science Private LimitedAnkur Manvar, Prasantkumar Manvar and 2 more are mutual person
-
Neoteric Agri Solutions Limited
Ankur Manvar, Prasantkumar Manvar and 2 more are mutual person
-
Oasis Agri Equipment Private Limited
Ankur Manvar, Prasantkumar Manvar and 2 more are mutual person
Charges (Loans)
₹20.00 M
₹7.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2024 | Axis Bank Limited | ₹2.00 Cr | Open |
| 21 Feb 2018 | Idbi Bank Limited | ₹7.00 M | Satisfied |
How Many Employees Work at Noble Genetics?
Unlock and access historical data on people associated with Noble Genetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
